NCT05419830Completed
Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses
Source: ClinicalTrials.gov · Last updated 17 Dec 2024
Brief summary (registry, in English)
In this study the investigators target three common and comorbid illnesses among older adults namely nocturia or waking at night to void, poor sleep and hypertension. The aim of this proposal is to test behavioral sleep intervention to improve sleep and nocturia vs switching the time of antihypertensive administration to improve nighttime and in turn daytime blood pressure control.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 10 Jun 2022
- Start date
- 1 Jun 2022
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- University of Pittsburgh
- Diseases
- High blood pressure
- NCT number
- NCT05419830
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Jun 2022 to the primary completion date, 30 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unstable or acute medical or central nervous system conditions
- Untreated, current, severe psychiatric condition
- Untreated, current, severe overactive bladder syndrome
- Currently diagnosed and/or treated Obstructive Sleep Apnea, Restless Legs Syndrome, parasomnia
- Congestive heart failure, by exam
Lab values
- Chronic kidney disease, stage III-V (eGFR\<60)
Other
- Post void residual \> 30ml
- Montreal cognitive assessment (MOCA) \<26
- \>14 alcohol drinks per week
- \>3 caffeinated drinks (\~300mg) per day
Who the study is looking for
- The study shall include: ambulatory and functionally-independent community-dwelling men and women aged 65+ years, with
- nocturia ≥2/night, and
- history of high blood pressure and receives one or more non-diuretic, once daily antihypertensive- angiotensin converting enzyme inhibitor (ACE-I), angiotensin receptor blocker (ARB), calcium channel blocker (CCB), beta blocker
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pittsburgh Coordinator of this site? Confirm its status | Pittsburgh | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.